- $16.61m
- $29.43m
- $37.06m
US STOCKS-Wall St inches higher as S&P 500 flirts with bull market confirmation
U.S. STOCKS ON THE MOVE-Exxon Mobil, Energy Fuels, Barrick Gold
Newscasts - Trading at Noon: Wall Street edges higher as new US jobless claims rise again
U.S. STOCKS ON THE MOVE-NeuroBo Pharma, EOG Resources, Nova LifeStyle
U.S. STOCKS ON THE MOVE-Velo3D, Nova LifeStyle, CytoSorbents
CytoSorbents falls as blood purification device fails to meet study goal
Brief: Cytosorbents Provides Update On The Star-T Trial And Reports Final Independent Data And Safety Monitoring Board Recommendation
Cytosorbents Corp expected to post a loss of 12 cents a share - Earnings Preview
Brief: Cytosorbents Announces Kathleen P. Bloch To Resume As Full-Time Chief Financial Officer
Brief: Cytosorbents Completes U.S. And Canadian Star-T Pivotal Trial
Brief: Cytosorbents Corp Says Instructed A Board Committee To Commence Investigation Into Certain Allegations Made By Former Employer Of Co's CFO
Cytosorbents Corp reports results for the quarter ended in June - Earnings Summary
Cytosorbents Corp expected to post a loss of 11 cents a share - Earnings Preview
Brief: Cytosorbents And Humedics Announce Theranostic Collaboration In The Field Of Liver Disease
Brief: CytoSorbents Completes Enrollment Of The STAR-T Pivotal Trial
Brief: Cytosorbents Announces Independent Data Safety Board Recommends Completion Of The Pivotal Star-T Trial
Brief: Cytosorbents Reports First Quarter 2023 Results
Cytosorbents Corp reports results for the quarter ended in March - Earnings Summary
Brief: Cytosorbents’ Pivotal Star-T Trial Reaches Second Key Milestone With 80 Patients Enrolled